Sun Pharma
SPARC Sun Pharma: US FDA approves company’s next generation BLU-U blue light photodynamic therapy (PDT) for actinic keratosis (Positive)
1550-1500 is a important support zone in sunpharma.
#FundamentalViews#TechnicalViews

125 likes·55 comments

















